Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 200MG/100ML (...DOSAGE - INJECTABLE;INJECTION - 200MG/100ML (2MG/ML)
USFDA APPLICATION NUMBER - 50778
DOSAGE - INJECTABLE;INJECTION - 50MG/25ML (2M...DOSAGE - INJECTABLE;INJECTION - 50MG/25ML (2MG/ML)
USFDA APPLICATION NUMBER - 50778
Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
92
PharmaCompass offers a list of Epirubicin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Epirubicin Hydrochloride manufacturer or Epirubicin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Epirubicin Hydrochloride manufacturer or Epirubicin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Epirubicin Hydrochloride API Price utilized in the formulation of products. Epirubicin Hydrochloride API Price is not always fixed or binding as the Epirubicin Hydrochloride Price is obtained through a variety of data sources. The Epirubicin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A E-ADM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E-ADM, including repackagers and relabelers. The FDA regulates E-ADM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E-ADM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of E-ADM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A E-ADM supplier is an individual or a company that provides E-ADM active pharmaceutical ingredient (API) or E-ADM finished formulations upon request. The E-ADM suppliers may include E-ADM API manufacturers, exporters, distributors and traders.
click here to find a list of E-ADM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A E-ADM DMF (Drug Master File) is a document detailing the whole manufacturing process of E-ADM active pharmaceutical ingredient (API) in detail. Different forms of E-ADM DMFs exist exist since differing nations have different regulations, such as E-ADM USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A E-ADM DMF submitted to regulatory agencies in the US is known as a USDMF. E-ADM USDMF includes data on E-ADM's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The E-ADM USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of E-ADM suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The E-ADM Drug Master File in Japan (E-ADM JDMF) empowers E-ADM API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the E-ADM JDMF during the approval evaluation for pharmaceutical products. At the time of E-ADM JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of E-ADM suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a E-ADM Drug Master File in Korea (E-ADM KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of E-ADM. The MFDS reviews the E-ADM KDMF as part of the drug registration process and uses the information provided in the E-ADM KDMF to evaluate the safety and efficacy of the drug.
After submitting a E-ADM KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their E-ADM API can apply through the Korea Drug Master File (KDMF).
click here to find a list of E-ADM suppliers with KDMF on PharmaCompass.
A E-ADM CEP of the European Pharmacopoeia monograph is often referred to as a E-ADM Certificate of Suitability (COS). The purpose of a E-ADM CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of E-ADM EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of E-ADM to their clients by showing that a E-ADM CEP has been issued for it. The manufacturer submits a E-ADM CEP (COS) as part of the market authorization procedure, and it takes on the role of a E-ADM CEP holder for the record. Additionally, the data presented in the E-ADM CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the E-ADM DMF.
A E-ADM CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. E-ADM CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of E-ADM suppliers with CEP (COS) on PharmaCompass.
A E-ADM written confirmation (E-ADM WC) is an official document issued by a regulatory agency to a E-ADM manufacturer, verifying that the manufacturing facility of a E-ADM active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting E-ADM APIs or E-ADM finished pharmaceutical products to another nation, regulatory agencies frequently require a E-ADM WC (written confirmation) as part of the regulatory process.
click here to find a list of E-ADM suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing E-ADM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for E-ADM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture E-ADM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain E-ADM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a E-ADM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of E-ADM suppliers with NDC on PharmaCompass.
E-ADM Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of E-ADM GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right E-ADM GMP manufacturer or E-ADM GMP API supplier for your needs.
A E-ADM CoA (Certificate of Analysis) is a formal document that attests to E-ADM's compliance with E-ADM specifications and serves as a tool for batch-level quality control.
E-ADM CoA mostly includes findings from lab analyses of a specific batch. For each E-ADM CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
E-ADM may be tested according to a variety of international standards, such as European Pharmacopoeia (E-ADM EP), E-ADM JP (Japanese Pharmacopeia) and the US Pharmacopoeia (E-ADM USP).
